Stock Spotlight: Commonwealth Bank of Australia (ASX:CBA)

As the current largest company listed on the ASX by market capitalisation, Commonwealth Bank of Australia (ASX:CBA) plays a pivotal role in both the national economy and investor portfolios. With a vast footprint across retail, business and institutional banking, CBA serves millions of customers throughout Australia, New Zealand and select global markets.


For investors, CBA shares may offer a rare combination of stability, long-term income potential and direct exposure to the strength of the Australian banking sector. Whether you’re targeting dividend income, building a defensive portfolio or tracking major banking stocks on the ASX, CBA may be a company worth close attention.


At Sharewise, we deliver expert-level, data-driven insights to help investors make confident decisions. Contact us today to uncover detailed insight about CBA and any other Australian stocks and for support on your financial journey!



About Commonwealth Bank of Australia.


Commonwealth Bank of Australia provides retail and commercial banking services in Australia, New Zealand, and internationally. It operates through Retail Banking Services, Business Banking, Institutional Banking and Markets, and New Zealand segments. The company offers savings and term deposit accounts, commonwealth direct investment accounts, and retail transaction accounts, as well as specialized accounts, such as statutory trust, society cheque, farm management, cash and treasury management, and business foreign currency deposit accounts. It also provides credit cards, personal and business loans, car and equipment finance, business overdrafts, margin lending, and international payment services; home loans; and buy-now-pay-later services. In addition, the company provides home and contents, car, health, life, income protection, pet, and travel insurance products. Further, it offers transaction banking, equity trading, and risk management products and services, as well as access to debt capital markets, capital raising, and investment and financial solutions. Commonwealth Bank of Australia was founded in 1911 and is based in Sydney, Australia.


Source: EODHD


What Makes CBA Stocks A Strong Competitor In The Banking Sector?


The CBA share price on the ASX typically draws close attention from investors—and for good reason. With the largest market capitalisation of any Australian bank, Commonwealth Bank of Australia presently holds a dominant position in retail banking, underpinned by industry-leading home lending volumes and a loyal customer base.


Financially, CBA bank shares currently outperforms its ASX banking peers. Its return on equity (ROE) sits at around 13.7%, reflecting strong profit generation relative to shareholder capital—a key metric that highlights CBA’s efficiency and long-term value creation. This level of ROE places CBA at the top of the Big Four and well above the broader sector average.


Its balance sheet also stands out. CBA maintains a strong Common Equity Tier 1 (CET1) ratio, which provides a robust capital buffer and gives the bank flexibility to absorb market shocks, support lending growth and return capital to shareholders. For investors, these financial strengths reinforce CBA’s reputation as a reliable, lower-risk banking stock—especially during periods of economic uncertainty or rising rates.


Compared to Westpac, NAB and ANZ, CBA stocks have consistently led in digital capability, earnings consistency and customer retention. NAB has built strength in business banking and SME lending, but falls short of CBA’s retail reach. ANZ’s international footprint adds growth potential but introduces additional exposure to global volatility, particularly across Asia-Pacific markets.


Westpac continues to recover from prolonged regulatory and compliance challenges. Although it has made progress in recent years, it still trails CBA in critical areas like technology investment and earnings reliability. In contrast, CBA  offers a compelling blend of scale, performance and trust—a combination few others in the sector can presently match.


Key Stats

Source: EODHD. Data as of 13/02/26.

Price Performance

Growth Potential

  • CBA is leading all its competitors on a closely monitored measure of customer satisfaction & engagement – Net Promoter Score (NPS). CBA has held the top position in the consumer category for 26 consecutive months. CBA has also returned to the number one position in business. CBA also holds the number position in MFI share – i.e. number of consumers who consider CBA their main financial institution – with 33.5% share in Retail (vs nearest peer 15.9%) and 26.9% share in Business.
  • Trades at a 3.7x Price to Book, and dividend yield of ~3.0% and trades at a premium to its peer group.
  • Improving macroeconomic environment which may see favourable higher interest rate hikes.
  • Better than expected economic conditions could result in provisions write-backs.
  • Potential pressure on net interest margins as competition intensifies with other major banks.
  • Sector leading return on tangible equity.
  • A well-diversified corporate book.
  • Improving CET1 ratio, which may in due course provide opportunity to undertake capital management initiatives.

Upcoming Innovations From Commonwealth Bank Of Australia ASX


Commonwealth Bank is, at present, widely regarded as the most digitally advanced of Australia’s major banks. It continues to make long-term investments in technology, positioning itself to improve customer experience, drive efficiency and stay ahead in an increasingly digital financial sector. For investors tracking Commonwealth Bank ASX, this forward-thinking approach allows them to stay proactive in an ever-evolving financial landscape.


CBA was one of the first banks in Australia to lead in mobile banking, and its digital capabilities remain well ahead of the pack. The CommBank app delivers real-time payments, cardless cash withdrawals, smart alerts and integrated budgeting tools. These features do more than enhance convenience—they reduce reliance on physical branches, cut operational costs and boost customer engagement. As adoption of mobile banking grows, CBA’s ability to scale services efficiently becomes a major competitive advantage.


In 2025, the bank opened a technology hub in Seattle to deepen its focus on generative AI and intelligent automation. More than 200 employees are being upskilled to develop AI-driven solutions that improve productivity and enhance digital customer experiences—such as predictive virtual assistants and automated service workflows. It’s a strategic move that positions CBA to respond faster and operate leaner than most competitors.


CBA is also exploring blockchain technologies, including smart contracts, real-time cross-border transactions and more secure compliance processes. At the same time, it’s investing in digital identity tools designed to reduce fraud and streamline customer onboarding—a critical innovation in a highly regulated sector.


For shareholders, these initiatives are part of a long-term strategy to protect margins, drive growth and future-proof operations. Among the Big Four, CBA shares on ASX continue to set the pace—and its innovation agenda plays a big role in maintaining that lead. Investors watching the CBA ASX chart can take confidence in a bank that isn’t just reacting to the future, but actively building it.


CBA Shareholder Returns & Investor Sentiment


CBA’s focus on innovation and efficiency continues to reward shareholders with consistent income and strong capital growth. Among its local banking rivals, it currently offers one of the most reliable dividend streams—a key reason why many income-focused investors turn to Commonwealth Bank dividends ASX as part of their long-term strategy. In February 2025, CBA paid a fully franked interim dividend of $2.25 per share, marking a 5% increase year on year. With a current yield of around 3.6–3.7%, the bank continues to meet expectations for stable, growing returns backed by a resilient balance sheet.


Over the past 12 months, CBA has delivered a total return of +25.36%, significantly outperforming most ASX-listed financial stocks. The CBA stock price ASX reached a record high of $167.61 in February 2025, driven by investor demand for defensive stocks with high-quality earnings. While the share price has since levelled off, its performance reflects the market’s long-standing confidence in CBA’s ability to generate reliable returns—both through dividends and capital appreciation.


Overall, investor sentiment around valuation is increasingly cautious. CBA is currently trading at a price-to-earnings (P/E) ratio of around 27x, which is a premium to both its historical average and the broader banking sector. Some analysts estimate fair value in the range of $107 to $120. However, despite these warnings, few investors are willing to bet against the stock. CBA remains a fixture in SMSF and long-term portfolios, valued for its low volatility and strong fundamentals. For prospective investors looking to buy CBA shares, many are watching for pullbacks rather than buying at peak levels.


Investment Tips For Buying Commonwealth Bank Of Australia (ASX: CBA) Stocks


For investors considering CBA shares, timing and portfolio role are just as important as the stock itself. CBA is better viewed as a reliable building block that offers consistency rather than rapid growth. This makes it especially appealing to long-term investors and SMSF holders seeking income and low-volatility exposure to the financial sector.


When the CBA ASX graph peaked at $167.61 in early 2025, many experienced investors avoided entering at the top—they waited patiently. Much like buying a quality home in a good suburb, the goal isn’t to find the absolute bottom, but to secure a stable asset at a reasonable price. For example, when CBA’s yield rises above 4% during a temporary dip, that moment often draws interest from income-focused investors looking to improve their return on entry.


It also helps to define what role CBA stocks should play in your broader portfolio. For many, it acts as a defensive anchor that counterbalances more volatile sectors like tech, mining or small caps. Strategies like reinvesting dividends through a Dividend Reinvestment Plan (DRP) can compound returns without increasing exposure to timing risk. In 2024, nearly 30% of eligible shareholders opted into CBA’s DRP, highlighting its popularity among long-term investors.


Reviewing the CBA share price on the ASX across multi-year periods can provide valuable insight into price behaviour during interest rate changes, dividend announcements or broader market corrections. Notably, CBA has historically bounced around the $135–$145 range before climbing to new highs that some chart watchers use to gauge entry points.


While past performance is never guaranteed, CBA’s consistency, earnings diversity and trusted brand—including asx:cba subsidiaries like CommSec and Bankwest—continue to support its role as a foundational holding in many Australian portfolios.

Key Risks



  • Intense competition for loans, as overall market growth rate moderates. Management in particular called out the increasing competitive pressure from Macquarie Bank (MQG).
  • Trades at a premium to peer group, with high competition potentially eroding its ROE.
  • Major banks, including CBA, are growing below system growth (i.e. losing market share).
  • Increase in bad and doubtful debts or increase in provisioning.
  • Funding pressure for deposits and wholesale funding (increased funding costs).
  • Regulatory and compliance risk
  • Australian housing property crash. 

Frequently Asked Questions.

  • What key financial ratios should investors analyse before buying CBA shares?

    The most relevant ratios include the price-to-earnings (P/E), currently around 27x, and the price-to-book (P/B), which highlights valuation relative to assets. Return on equity (ROE), at approximately 13.7%, reflects profitability, while the CET1 ratio offers insight into capital strength and resilience. Together, these metrics help assess whether CBA shares offer strong value and financial stability.

  • How does Commonwealth Bank Of Australia maintain profitability during interest rate fluctuations?

    CBA uses flexible loan pricing, diversified lending and disciplined cost control to manage interest rate pressure. It also applies hedging strategies and invests in technology to boost efficiency, helping preserve margins across different rate cycles.

  • How does the CBA ASX chart indicate potential resistance & support levels for traders?

    The CBA ASX chart shows recurring resistance around $167 and support between $135–$145—key zones where price movements have historically reversed. Chart analysts often use these levels to guide decisions on entry points, stop losses or profit-taking.

  • What role do CBA shares play in income-focused portfolios?

    CBA stocks are a mainstay in many SMSFs and income-driven portfolios due to their consistent, fully franked dividends. With a yield near 3.6–3.7%, they offer stable income and relatively low volatility—making them a strong candidate for long-term, passive investing strategies.

  • What are the long-term implications of CBA’s investments in AI & digital banking?

    CBA’s focus on AI, blockchain and mobile platforms aims to reduce costs, enhance customer experience and improve risk controls. For long-term investors in ASX:CBA, these innovations may support stronger margins, higher retention and future-proofed operations in a tech-driven market.

Subscribe to our newsletter

Disclaimer: This article does not constitute financial advice nor a recommendation to invest in the securities listed. The information presented is intended to be of a factual nature only. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing.

Is a Share Advisor

right for you?

May 6, 2026
The RBA has lifted rates to 4.35%. Here’s what it means for households, inflation, markets, sector performance and the outlook for Australian investors.
May 6, 2026
About The a2 Milk Co Ltd The a2 Milk Company Limited, together with its subsidiaries, sells A2-type protein type branded milk and related products in Australia, New Zealand, China, rest of Asia, and the United States. The company offers infant milk formula; other nutritional products and milk; manufactures and sells nutritional and ingredients products, as well as provides rent, royalty, and licensing services. It offers its products under the a2 Milk and a2 Platinum brands. The company was formerly known as A2 Corporation Limited and changed its name to The a2 Milk Company Limited in April 2014. The a2 Milk Company Limited was incorporated in 2000 and is based in Auckland, New Zealand. Source: EODHD Key Stats
May 5, 2026
About Meta Platforms Inc Meta Platforms, Inc. engages in the development of products that enable people to connect and share with friends and family through mobile devices, personal computers, virtual reality (VR) headsets, and AI glasses in the United States, Canada, Europe, Asia-Pacific, and internationally. It operates through two segments, Family of Apps (FoA) and Reality Labs (RL). The FoA segment offers Facebook, which enables people to build community through feed, reels, stories, groups, marketplace, and other; Instagram that brings people closer through Instagram feed, stories, reels, live, and messaging; Messenger, a messaging application for people to connect with friends, family, communities, and businesses across platforms and devices through text, audio, and video calls; Meta AI, an assistant that's available across apps, as a stand-alone app, on AI glasses, and on the web; Threads, an application for text-based updates and public conversations; and WhatsApp, a messaging application that is used by people and businesses to communicate and transact in a private way. The RL segment provides virtual and augmented reality products, including consumer hardware, software, and content that help people feel connected anytime and anywhere, as well as Meta Quest devices that enable social experiences across gaming, fitness, entertainment, and more. The segment also includes wearables such as AI glasses like Ray Ban Meta and Oakley Meta glasses, featuring Meta AI for advanced conversational and hands free interaction; and the Meta Ray Ban Display, which combines AI glasses with an integrated lens display and the Meta Neural Band, a wrist worn device using electromyography that lets people control their AI glasses through neuromuscular signals. The company was formerly known as Facebook, Inc. and changed its name to Meta Platforms, Inc. in October 2021. The company was incorporated in 2004 and is headquartered in Menlo Park, California. Source:EODHD Key Stats
May 5, 2026
About Amazon.com Inc Amazon.com, Inc. engages in the retail sale of consumer products, advertising, and subscriptions service through online and physical stores in North America and internationally. The company operates through three segments: North America, International, and Amazon Web Services (AWS). It also manufactures and sells electronic devices, including Kindle, fire tablets, fire TVs, echo, ring, blink, and eero; and develops and produces media content. In addition, the company offers programs that enable sellers to sell their products in its stores; and programs that allow authors, independent publishers, musicians, filmmakers, Twitch streamers, skill and app developers, and others to publish and sell content. Further, it provides compute, storage, Artificial intelligence, database, analytics, machine learning, and other services, as well as advertising services through programs, such as sponsored ads, display, and video advertising. Additionally, the company offers Amazon Prime, a membership program. The company's products offered through its stores include merchandise and content purchased for resale and products offered by third-party sellers. It serves consumers, sellers, developers, enterprises, content creators, advertisers, and employees. The company was incorporated in 1994 and is headquartered in Seattle, Washington. Source:EODHD Key Stats
May 1, 2026
Earnings may beat expectations, but guidance drives markets. Learn how to read forward outlooks, tone and signals to better interpret stock price reactions.
May 1, 2026
About Visa Inc. Visa Inc. operates as a payment technology company in the United States and internationally. The company operates VisaNet, a transaction processing network that enables authorization, clearing, and settlement of payment transactions. It also offers credit, debit, and prepaid card products; tap to pay, tokenization, and click to pay services; Visa Direct, a solution that facilitates the delivery of funds to eligible cards, bank accounts, and digital wallets; Visa B2B Connect, a multilateral business-to-business cross-border payments network; Visa Cross-Border Solution, a cross-border consumer payments solution; and Visa DPS that provides a range of value-added services, including fraud mitigation, dispute management, data analytics, campaign management, a suite of digital solutions, and contact center services. The company also provides acceptance solutions, which include Cybersource and Authorize.net that provides new and enhanced payment integrations with ecommerce platforms, enabling sellers and acquirers to offer tailored commerce experiences; risk and identity solutions, such as Visa Advanced Authorization, Visa Secure, Visa Consumer Authentication Service, Visa Protect Authentication Intelligence, and Visa Provisioning Intelligence; and Visa Consulting and Analytics, a payment consulting advisory services. It provides its services under the Visa, Visa Electron, Interlink, V PAY, and PLUS brands. The company serves merchants, financial institutions, and government entities. Visa Inc. was founded in 1958 and is headquartered in San Francisco, California. Source:EODHD Key Stats
May 1, 2026
About Telix Pharmaceuticals Ltd Telix Pharmaceuticals Limited, a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals. The company operates through three segments: Precision Medicine, Therapeutics, and Manufacturing Solutions. Its lead therapeutic product candidate is TLX591, a lutetium-labeled radio antibody-drug conjugate (rADC), which is in a Phase 3 clinical trial in patients with advanced prostate cancer. The company develops TLX250, an rADC for treating advanced metastatic kidney cancer; TLX101, a systemic therapy for the treatment of glioblastoma; TLX66, a product candidate for bone marrow conditioning for hematopoietic stem cell transplant conditioning; and Illuccix and Gozellix for the treatment of prostate cancer. The company is also developing TLX592, a prostate cancer therapy candidate for targeted alpha therapy based on its proprietary RADmAb-engineered antibody technology; TLX252 for the treatment of patients with advanced metastatic kidney cancer; TLX400, a bladder fibroblast activation protein for treating various tumors; TLX102, a large amino acid transporter-targeting small molecule-based alpha therapy candidate for the treatment of glioblastoma and multiple myeloma; TLX300 for treating soft tissue sarcoma; and TLX090, a bone-seeking agent for bone metastases and pain palliation. In addition, it is developing BiPASS, which is in Phase 3 clinical trial for prostate cancer diagnosis; AlFluor, a novel PET radiochemistry solution; TLX250-Px, a PET diagnostic imaging agent; and TLX101-Px, a radiolabeled amino acid PET agent. It operates in Australia, Belgium, Canada, the United Kingdom, the United States, and internationally. The company has strategic collaboration with University Hospital Essen. The company was founded in 2015 and is headquartered in North Melbourne, Australia. Source:EODHD Key Stats
April 30, 2026
The UAE leaves OPEC on 1 May. Oil prices did not move. Here is why the near-term calm is masking a structural shift investors should not ignore.
April 29, 2026
Earnings are beating expectations, but the market is cautious. See what S&P 500 Q1 results reveal about market concentration and portfolio positioning.
April 28, 2026
Get the latest on Genesis Minerals Limited (ASX:GMD), including stock performance, technical analysis, forecasts & key insights. See if GMD supports your goals.